1. Printz C (2017) Cancer death rate declines 25% after 1991 peak. Cancer 123(14):2593
2. Momenimovahed Z, Momenimovahed S, Allahqoli L, Salehiniya H (2022) Factors related to the delay in diagnosis of breast cancer in the word: a systematic review. Indian J Gynecol Oncol 20(3):1–21
3. Campos CD, Jackson JM, Witek MA, Soper SA (2018) Molecular profiling of liquid biopsy samples for precision medicine. Cancer J 24(2):93
4. Rifai N, Gillette MA, Carr SA (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24(8):971–983
5. Füzéry AK, Levin J, Chan MM, Chan DW (2013) Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges. Clin Proteomics 10(1):1–14